Ameliorative effect of adenosine on hypoxia-reoxygenation injury in LLC-PK1, a porcine kidney cell line

被引:9
作者
Yonehana, T [1 ]
Gemba, M [1 ]
机构
[1] Osaka Univ Pharmaceut Sci, Div Pharmacol, Osaka 5691094, Japan
关键词
acute renal failure; hypoxia and reoxygenation; adenosine A(2) receptor; cyclic AMP; LLC-PK1; cell;
D O I
10.1254/jjp.80.163
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied the effects of adenosine on injury caused by hypoxia and reoxygenation in LLC-PK1 cells. Lactate dehydrogenase and gamma-glutamyltranspeptidase were released from cells exposed to hypoxia for 6 hr and then reoxygenation for 1 hr. The addition of adenosine at 100 mu M to the medium before hypoxia began significantly decreased enzyme leakage into medium during both hypoxia and reoxygenation. The adenosine A(1)-receptor agonist, R(-)-N-6-(2-phenylisopropyl)adenosine (R-PIA), at the concentration of 100 mu M, did not affect enzyme release, but the adenosine A(2)-receptor agonist 2-p-[2-carboxyethyl]phenethyl-amino-5'-N-ethylcarboxamido-adenosine hydrochloride (CGS 21680) at the concentration of 100 nM, suppressed the injury caused by hypoxia and reoxygenation. There were decreases in cAMP contents and ATP levels in LLC-PK1 cells injured by hypoxia and reoxygenation. Adenosine (100 mu M) restored ATP levels in the cells during reoxygenation. With adenosine, the intracellular cAMP level was increased prominently during reoxygenation. These results suggest that adenosine protects LLC-PK1 cells from injury caused by hypoxia and reoxygenation by increasing the intracellular cAMP level via adenosine A(2) receptor.
引用
收藏
页码:163 / 167
页数:5
相关论文
共 27 条
[1]  
BOEHM S, 1994, N-S ARCH PHARMACOL, V350, P454
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
CADNAPAPHORNCHAI P, 1991, J PHARMACOL EXP THER, V257, P774
[4]   AMINOPHYLLINE ENHANCES RESTING CA2+ CONCENTRATIONS AND TWITCH TENSION BY ADENOSINE RECEPTOR BLOCKADE IN RANA-PIPIENS [J].
CLARK, KI ;
BARRY, SR .
JOURNAL OF PHYSIOLOGY-LONDON, 1994, 481 (01) :129-137
[5]  
COLLIS MG, 1993, TRENDS PHARMACOL SCI, V14, P360
[6]  
CRONSTEIN BN, 1985, J IMMUNOL, V135, P1366
[7]  
DALZIEL HH, 1994, PHARMACOL REV, V46, P449
[8]   STIMULATION OF ADENYLATE-CYCLASE ACTIVITY VIA ADENOSINE-A2 RECEPTORS IN ISOLATED TUBULES OF THE RABBIT RENAL-CORTEX [J].
FREISSMUTH, M ;
NANOFF, C ;
TUISL, E ;
SCHUETZ, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 138 (01) :137-140
[9]   PROTECTION BY BENIDIPINE HYDROCHLORIDE (KW-3049), A CALCIUM-ANTAGONIST, OF ISCHEMIC KIDNEY IN RATS VIA INHIBITIONS OF CA-OVERLOAD, ATP-DECLINE AND LIPID-PEROXIDATION [J].
KARASAWA, A ;
KUBO, K .
JAPANESE JOURNAL OF PHARMACOLOGY, 1990, 52 (04) :553-562
[10]   ASSAY OF PICOMOLE AMOUNTS OF ATP, ADP, AND AMP USING LUCIFERASE ENZYME-SYSTEM [J].
KIMMICH, GA ;
RANDLES, J ;
BRAND, JS .
ANALYTICAL BIOCHEMISTRY, 1975, 69 (01) :187-206